Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study
{{output}}
What is this summary about? Sparsentan (FILSPARI®) is a once-daily pill for people with Immunoglobulin A (IgA) nephropathy who are at high risk for worsening kidney disease. Early results from a research study (clinical trial) called PROTECT showed that after... ...
